Retraction
Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase (RRM2): a novel therapeutic strategy in pancreatic cancer
Paper Information
Record ID:
42612
Author(s):
Publication Date:
August 04, 2004
Retraction Date:
February 10, 2023
(2.8 years years ago)
Subjects:
Institution:
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass USACountry:
🇺🇸 United StatesArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (58)
58
Total Citations1
Post-Retraction(1.7%)
57
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
1
Within 1 year
0
After 2+ years
5
Days since retraction (latest)
Immunotherapeutic strategies employing RNA interference technology for the control of cancers
Chih‐Ping Mao, Chien‐Fu Hung, T.‐C. Wu
Journal of Biomedical Science
Published: Nov 2006
23 citations
23 citations
5932 days before retraction
Ribonucleotide Reductase Inhibitors and Future Drug Design
Jimin Shao, Bisheng Zhou, Bernard Chu et al. (4 authors)
Current Cancer Drug Targets
Published: Jun 2006
279 citations
279 citations
6070 days before retraction
Gene Therapy Strategies for Hepatocellular Carcinoma
Lih‐Hwa Hwang
Journal of Biomedical Science
Open Access
Published: Apr 2006
33 citations
33 citations
6139 days before retraction
Paper citing Retrovirally mediated RNA interference targeting t...
Unknown Authors
Unknown Journal
Published: Apr 2006
6159 days before retraction
Prospects of RNA interference therapy for cancer
Sara I. Pai, Y-Y Lin, Bruno Macaes et al. (6 authors)
Gene Therapy
Open Access
Published: Dec 2005
351 citations
351 citations
6273 days before retraction
2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) Directly Targets Mitochondrial Glutathione to Induce Apoptosis in Pancreatic Cancer
Ismael Samudio, Marina Konopleva, Numsen Hail et al. (13 authors)
Journal of Biological Chemistry
Open Access
Published: Aug 2005
105 citations
105 citations
6379 days before retraction
siRNA as a new drug: intellectual property
Raymond M. Schiffelers, Sarianne C van Kolfschoten, M. Van Dijk et al. (6 authors)
Expert Opinion on Therapeutic Patents
Published: Feb 2005
2 citations
2 citations
6583 days before retraction
The Genetic Basis of Sporadic Pancreatic Cancer
Mario Baumgart, Ernst Heinmöller, O. Horstmann et al. (5 authors)
Analytical Cellular Pathology
Open Access
Published: Jan 2005
28 citations
28 citations
6614 days before retraction
Quick Stats
Total Citations:
58
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025